The Trustees of The University of Pennsylvania;Novartis AG
发明人:
申请号：
EP19158368.1
公开号：
EP3539986A1
申请日:
2014.03.15
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The invention provides compositions and methods for treating diseases associated with expression of CD19. The invention also relates to chimeric antigen receptor (CAR) specific to CD19, vectors encoding the same, and recombinant T cells comprising the CD19 CAR. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises a CD19 binding domain.
